Skip to Main Content

Paper Details

Glasdegib as maintenance therapy for patients with AML and MDS patients at high risk for postallogeneic stem cell transplant relapse.
Blood Adv
16
2020
Author NameAffiliation
Clayton A SmithUniversity of Colorado
Daniel A PollyeaUniversity of Colorado
  • 1 - 2

Datasets

Release 1.2